abstract |
The present invention relates to novel isoxazole-pyridine derivatives of formula (I) and pharmaceutically acceptable salts and esters thereof. The active compounds of the present invention have affinity and selectivity for GABA A α5 receptors. The invention also relates to a process for the preparation of the active compounds of formula (I), pharmaceutical compositions containing them and their use as medicaments: Formula I Where R 1 , R 2 , R 3 and L are as described herein. |